FORM & FUNCTION (AA Metabolism) Flashcards

1
Q

Protein structure:

A

-primary structure: AA residues
-secondary structure (alpha-helix, beta-sheet)
-tertiary structure (polypeptide chain)
-quaternary structure (assembled subunits, dictates the function)
*digestion or muscle breakdown (starvation)
*protein contributes to 10-15% of energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amino acids:

A

-20 AA
>9 essential (dietary only)
>11 non-essential (synthesized by body)
-can be both an acid or base depending on the R group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Components of an AA:

A

-side chain
-amino group
-carboxyl group (proton donor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AA catabolism:

A
  1. Ingested protein (stomach)
  2. Polypeptides (small intestine)
  3. Amino acids (small intestine)
  4. Amino acids (serum – most goes to the liver)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AA catabolism location:

A

-liver governs distribution of AA (like an airport)
-most AA are catabolized in the liver except:
>BCAA (skeletal muscles)
>Gln (intestine, kidney)
>Val (brain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AA pool:

A
  1. Building blocks to synthesize new tissue proteins
  2. Forming non-protein cellular molecules (ex. NTs)
  3. Generates intermediates to feed into other energy pathways (via alpha-keto acids)
    *excess AA cannot be stored
    *will likely end up as fat molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Goal of excess AA breakdown:

A

-to form alpha-keto acids (energy precursors)
>gluconeogenesis
>lipogenesis
>ketogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alpha-keto acids:

A

-requires the removal of alpha-amino group (1st step of catabolism)
>alpha-ketoglutarate acts as an acceptor of the alpha-amino group
*transamination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Transamination:

A

-alpha-ketoglutarate accepts an alpha-amino group
-catalyzes by transaminases (aminotransferase)
-some require additional enzymes, but all end products are alpha-keto acids that form an energy metabolite
*get glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical relevance: aminotransferase:

A

-serum activity of aminotransferase used as an indicator of tissue damage
-enzyme is normally inside the tissue
*release into serum indicates tissue damage
Ex. ALT and AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alanine transaminase (ALT):

A

-alanine to pyruvate
-found in kidney, heart, muscle and liver (very high)
-high levels (>2-3 fold increase) indicate liver damage in cats and dogs
*not used in large animals (low ALT activity in liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aspartate transaminase (AST):

A

-aspartate to oxaloacetate
-found in liver, RBC, heart, skeletal muscle (highest conc.)
-high levels indicate possible muscle trauma (rhabdomyolysis) OR liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fate of Glutamate:

A

-universal end product of transamination
-processed in the liver
-De/transaminated to recycle alpha-ketoglutarate
-NH4+ enters the urea cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NH+ enters the urea cycle:

A

-important step to remove toxic nitrogenous waste (renal section)
*nitrogen are toxic in high amounts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AA acid substrates for CAC:

A

-acetyl-CoA is NOT glucogenic
>1 oxaloacetate is required to form citrate
*this mechanism is critical for starvation survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glucogenic AA:

A

-form oxaloacetate to enter gluconeogenesis

17
Q

Ketogenic AA:

A

-form acetyl-CoA or acetoacetyl-CoA

18
Q

Non protein derivatives:

A

-tyrosine derivatives
-glutamate derivatives

19
Q

Tyrosine derivatives:

A

-catecholamines
-Thyroid hormones

20
Q

Catecholamines:

A

-amine containing catechol (neurotransmitter & hormone)
Ex. dopamine, E and NE

21
Q

Dopamine:

A

-NT
-regulates motor movement

22
Q

NE and E:

A

-NT and hormone
-produced by adrenal cortex
-regulates flight-or-flight response
-acts on alpha and beta receptors to stimulate CNS

23
Q

Thyroid hormones examples:

A

-tetraiodothyronine (T4)
-triiodothyronine (T3)

24
Q

Thyroid hormones:

A

-2x tyrosine + iodine molecules
-iodine from diet (iodized salt, seafood, dairy)
-every cell requires thyroid hormones to regulate metabolism
*hypothyroidism (endocrine disease) linked to obesity

25
Q

Glutamate derivatives:

A

-glutamate is a universal produced when alpha-ketoglutarate is broken down
-GABA: gamma-aminobutyric acid
*major inhibitory NT in the CNS
>reduces neuronal excitability/block nerve impulses

26
Q

GABA as NT:

A
  1. Released from presynaptic neuron
  2. Binds to postsynaptic neuron
  3. Cl- enters postsynaptic neuron
    -negative charge causes inhibitory post synaptic potential=*inhibits nerve impulse
    >hyperpolarisation
27
Q

Sedatives:

A

-enhance GABA effects
Examples:
-benzodiazepine
-zolpidem (Ambien)

28
Q

Glutamate as NT:

A

-serves as an excitatory NT
1. Released from presynaptic neuron
2. Binds to postsynaptic neuron
3. Na+ enters postsynaptic neuron
-positive charge causes excitatory post synaptic potential
>depolarisation

29
Q

GABA Clinical Relevance: Epilepsy

A

-epilepsy: over stimulation/excitation
-excess glutamate (depolarization) or inadequate GABA (hyperpolarization)
-over-excitation of neuronal activity

30
Q

Therapeutic: GABA agonists:

A

-phenobarbital
-benzodiazepine

31
Q

Ivermectine: (GABA related drugs)

A

-in parasite control
-broad spectrum: heartworm, lice, scabies (nematodes and arthropod)
-triggers paralysis in parasites (enhance inhibitory NT)
-low toxicity in mammals
*in mammals, removed by a drug pump called MDR1, does not cross BBB

32
Q

GABA neurons (ivermectine):

A

-mammals: located in CNS
-arthropods & nematodes: PNS

33
Q

MDR1:

A

-multiple drug resistance 1

34
Q

Ivermectin sensitivity: clinical signs

A

-most commonly ataxia or depression
-cattle: 20-40x the therapeutic dose (TD)
-horses: 10x TD
-pigs: 100x TD
-dogs! Collies: 15-30x the therapeutic dose
>beagles: greater than 200x TD

35
Q

Collies:

A

-70% frequency have the MDR1 mutation